How Will the Market React to Theratechnologies Inc (THTX) Stock Getting a Bullish Rating

Theratechnologies Inc (THTX) stock is down 4.44% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Theratechnologies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on THTX!

See Full THTX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With THTX Stock Today?

Theratechnologies Inc (THTX) stock is lower by -4.39% while the S&P 500 is up 0.52% as of 11:16 AM on Thursday, Jul 13. THTX is lower by -$0.04 from the previous closing price of $0.90 on volume of 65,374 shares. Over the past year the S&P 500 has risen 17.71% while THTX is lower by -57.43%. THTX lost -$0.08 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Theratechnologies Inc click here.

More About Theratechnologies Inc

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Click Here to get the full Stock Report for Theratechnologies Inc stock.